Pricing Log in Create free account

Insight Molecular Diagnostics Inc. (IMDX) vs Quantum Cyber N.V (QUCY)

Insight Molecular Diagnostics Inc. and Quantum Cyber N.V are both Diagnostics & Research companies. Insight Molecular Diagnostics Inc. and Quantum Cyber N.V are of similar size ($100.1M and $95.1M). Quantum Cyber N.V grew revenue faster over the last twelve months: 69.0% against −60.8%. Quantum Cyber N.V has the higher net margin (0.00% vs −2,955.6%) and the lower return on invested capital (−194.0% vs 0.00%). Across the 17 metrics below, Quantum Cyber N.V leads on 9 and Insight Molecular Diagnostics Inc. on 8.

Valuation

Metric IMDX QUCY Diagnostics & Research median
P/E n/m n/m 35.56
P/S 66.24 21.53 4.37
P/B n/m 0.95 3.06
Price to free cash flow n/m n/m 35.76
EV/EBITDA n/m n/m 24.35
EV/Sales 55.72 8.36 5.51
Earnings yield (49.50%) (1,121.13%) (1.89%)
Free cash flow yield (28.02%) (86.11%) (0.15%)

Profitability

Metric IMDX QUCY Diagnostics & Research median
Gross margin 48.32% 56.91% 50.89%
Operating margin (3,011.86%) 0.00% (8.57%)
Net margin (2,955.63%) 0.00% (6.37%)
Free cash flow margin (1,856.23%) 0.00% 0.00%
Return on equity 488.68% (325.19%) (2.92%)
Return on assets (123.46%) (165.20%) (6.71%)
Return on invested capital 0.00% (193.99%) 0.00%

Growth

Metric IMDX QUCY Diagnostics & Research median
Revenue growth (TTM) (60.77%) 68.99% 7.69%
EPS growth (last fiscal year) 64.59% 87.92% 25.92%
Revenue growth, 5-year CAGR 27.24% 1.70% 7.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric IMDX QUCY Diagnostics & Research median
Debt to equity (0.04) 0.00 0.11
Current ratio 2.00 5.56 2.02
Net debt to EBITDA (0.67) (0.01) 0.70

Dividend

Metric IMDX QUCY Diagnostics & Research median
Dividend yield — — 0.66%
Payout ratio — — 0.20

Size

Metric IMDX QUCY Diagnostics & Research median
Market cap 100.14m 95.07m 2.16b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack